Pharmaceuticals
-
Move opioid patients to alternative therapies – guidance
A drive to reduce opioid prescriptions in primary care is having success as patients move to therapeutic alternatives to drugs, it was announced today. Read more
-
Vaccine may improve long COVID symptoms
Vaccination may reduce the severity and impact of long COVID symptoms, researchers report today. Read more
-
Three COVID treatments gain approval
Regulators today endorse three medicines for treating adults with COVID-19 as part of a clinical and cost-effectiveness review. Read more
-
Breakthrough made in next generation cancer treatment
A new generation of light-activated cancer treatments has become a step closer to reality, UK researchers have revealed. Read more
-
COVID protection drug rejected
A drug designed to protect vulnerable patients against COVID is unlikely to be effective enough, according to UK regulators. Read more
-
Catastrophic’ rise in antibiotic resistance in Iraq
Decades of wars and conflict in Iraq have led to a “catastrophic” rise in antibiotic resistance in the country, international experts warn today. Read more
-
Most antidepressants ‘ineffective’ for pain relief
Most antidepressants are ineffective for pain relief – or evidence to support their use is inconclusive, according to new analysis published last night. Read more
-
Concern over switching Parkinson’s drugs
Patients with Parkinson’s disease should be protected against unplanned switching of the brand of drugs they take, campaigners have warned. Read more
-
New indication for cannabis treatments
The NHS is to support a new use of cannabis-derived medicines, it has been announced. Read more
-
Chemotherapy first approach reduces risk of colon cancer return
Chemotherapy before surgery reduces the risk of colon cancer returning in two years by 28%, according to a new study. Read more